SCHEMBL4406502

SCHEMBL4406502

COC(=O)c1sc(N)cc1OCC[Si](C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
MAPK14 Q16539 1/20 0.40
HSD17B10 Q99714 5/20 0.37
KMT2A Q03164 3/20 0.37
TSHR P16473 1/20 0.37
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 5/20 0.36
HPGD P15428 4/20 0.36
ALOX15 P16050 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPK1 P28482 1/20 0.36
SHMT2 P34897 1/20 0.36
GLA P06280 2/20 0.35
GAA P10253 2/20 0.35
MEN1 O00255 1/20 0.35
ATM Q13315 1/20 0.35
NPC1 O15118 2/20 0.35
CASP3 P42574 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4404192 0.79 MAPT (0.37) MAPTKMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL3255840 0.74 MAPT (0.56) MAPTHSD17B10KMT2AALDH1A1KDM4E
SCHEMBL5141389 0.74 MAPT (0.44) MAPTHSD17B10KMT2AALDH1A1KDM4E
SCHEMBL31078685 0.70 MAPT (0.42) MAPTHSD17B10KMT2ATSHRALDH1A1
SCHEMBL381164 0.69 MAPK14 (0.52) MAPTMAPK14HSD17B10KMT2ATSHR
SCHEMBL31078754 0.69 MAPT (0.41) MAPTHSD17B10KMT2ATSHRALDH1A1
Hydrochloric Acid SCHEMBL5445499 0.67 MAPK14 (0.51) MAPTMAPK14HSD17B10KMT2ATSHR
SCHEMBL8570554 0.67 L3MBTL1 (0.52) MAPTMAPK14HSD17B10KMT2ATSHR
SCHEMBL31078531 0.67 KDM4E (0.42) MAPTKMT2AALDH1A1KDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL8570552 0.66 L3MBTL1 (0.51) MAPTMAPK14HSD17B10KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924572-B1 REGIOSELECTIVE PROCESS FOR PREPARING BENZIMIDAZOLE THIOPHENES SMITHKLINE BEECHAM CORP (US) 2009-12-30 EP disclosed
US-20080249301-A1 Regioselective Process for Preparing Benzimidazole Thiophenes SMITHKLINE BEECHAM CORPORATION 2008-10-09 US disclosed
US-20080249301-A1 Regioselective Process for Preparing Benzimidazole Thiophenes SMITHKLINE BEECHAM CORPORATION 2008-10-09 US disclosed
EP-1924572-A1 REGIOSELECTIVE PROCESS FOR PREPARING BENZIMIDAZOLE THIOPHENES SmithKline Beecham Corporation (US) 2008-05-28 EP disclosed
WO-2007030366-A1 REGIOSELECTIVE PROCESS FOR PREPARING BENZIMIDAZOLE THIOPHENES SMITHKLINE BEECHAM CORPORATION (US) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249301-A1 Regioselective Process for Preparing Benzimidazole Thiophenes CYP3A4, CYP2C19, CYP2B6 MAPT 2606/4885MAPK14 2162/4885HSD17B10 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.